Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Identifying Challenges and Risks Associated with the Analysis of Major Mycotoxins in Feed and Botanicals.

Patil US, King S, Holleran S, White K, Stephenson C, Reuther J.

J AOAC Int. 2019 Jun 25. doi: 10.5740/jaoacint.19-0105. [Epub ahead of print]

PMID:
31239007
2.

Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism.

Reyes-Soffer G, Sztalryd C, Horenstein RB, Holleran S, Matveyenko A, Thomas T, Nandakumar R, Ngai C, Karmally W, Ginsberg HN, Ramakrishnan R, Pollin TI.

Arterioscler Thromb Vasc Biol. 2019 Jan;39(1):63-72. doi: 10.1161/ATVBAHA.118.311476.

PMID:
30580564
3.

Effects of mipomersen, an apolipoprotein B100 antisense, on lipoprotein (a) metabolism in healthy subjects.

Nandakumar R, Matveyenko A, Thomas T, Pavlyha M, Ngai C, Holleran S, Ramakrishnan R, Ginsberg HN, Karmally W, Marcovina SM, Reyes-Soffer G.

J Lipid Res. 2018 Dec;59(12):2397-2402. doi: 10.1194/jlr.P082834. Epub 2018 Oct 7.

PMID:
30293969
4.

CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects.

Thomas T, Zhou H, Karmally W, Ramakrishnan R, Holleran S, Liu Y, Jumes P, Wagner JA, Hubbard B, Previs SF, Roddy T, Johnson-Levonas AO, Gutstein DE, Marcovina SM, Rader DJ, Ginsberg HN, Millar JS, Reyes-Soffer G.

Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1770-1775. doi: 10.1161/ATVBAHA.117.309549. Epub 2017 Jul 20.

5.

Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E.

Millar JS, Lassman ME, Thomas T, Ramakrishnan R, Jumes P, Dunbar RL, deGoma EM, Baer AL, Karmally W, Donovan DS, Rafeek H, Wagner JA, Holleran S, Obunike J, Liu Y, Aoujil S, Standiford T, Gutstein DE, Ginsberg HN, Rader DJ, Reyes-Soffer G.

J Lipid Res. 2017 Jun;58(6):1214-1220. doi: 10.1194/jlr.M074880. Epub 2017 Mar 17.

6.

Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans.

Reyes-Soffer G, Pavlyha M, Ngai C, Thomas T, Holleran S, Ramakrishnan R, Karmally W, Nandakumar R, Fontanez N, Obunike J, Marcovina SM, Lichtenstein AH, Matthan NR, Matta J, Maroccia M, Becue F, Poitiers F, Swanson B, Cowan L, Sasiela WJ, Surks HK, Ginsberg HN.

Circulation. 2017 Jan 24;135(4):352-362. doi: 10.1161/CIRCULATIONAHA.116.025253. Epub 2016 Dec 16.

7.

Immunization Data Exchange With Electronic Health Records.

Stockwell MS, Natarajan K, Ramakrishnan R, Holleran S, Forney K, Aponte A, Vawdrey DK.

Pediatrics. 2016 Jun;137(6). pii: e20154335. doi: 10.1542/peds.2015-4335. Epub 2016 May 5.

8.

Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects.

Millar JS, Reyes-Soffer G, Jumes P, Dunbar RL, deGoma EM, Baer AL, Karmally W, Donovan DS, Rafeek H, Pollan L, Tohyama J, Johnson-Levonas AO, Wagner JA, Holleran S, Obunike J, Liu Y, Ramakrishnan R, Lassman ME, Gutstein DE, Ginsberg HN, Rader DJ.

J Clin Invest. 2016 Apr 1;126(4):1603-4. doi: 10.1172/JCI87364. Epub 2016 Apr 1. No abstract available.

9.

Influence of Gender and Gender-Specific Recommendations on Adolescent Human Papillomavirus Vaccination.

Teplow-Phipps RL, Papadouka V, Benkel DH, Holleran S, Ramakrishnan R, Rosenthal SL, Soren K, Stockwell MS.

Am J Prev Med. 2016 Aug;51(2):161-169. doi: 10.1016/j.amepre.2016.01.030. Epub 2016 Mar 28.

PMID:
27032464
10.

Double Burden of Undernutrition and Obesity in Palestinian Schoolchildren: A Cross-Sectional Study.

Massad S, Deckelbaum RJ, Gebre-Medhin M, Holleran S, Dary O, Obeidi M, Bordelois P, Khammash U.

Food Nutr Bull. 2016 Jun;37(2):144-52. doi: 10.1177/0379572116637720. Epub 2016 Mar 29.

PMID:
27026740
11.

Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein.

Reyes-Soffer G, Millar JS, Ngai C, Jumes P, Coromilas E, Asztalos B, Johnson-Levonas AO, Wagner JA, Donovan DS, Karmally W, Ramakrishnan R, Holleran S, Thomas T, Dunbar RL, deGoma EM, Rafeek H, Baer AL, Liu Y, Lassman ME, Gutstein DE, Rader DJ, Ginsberg HN.

Arterioscler Thromb Vasc Biol. 2016 May;36(5):994-1002. doi: 10.1161/ATVBAHA.115.306680. Epub 2016 Mar 10. Erratum in: Arterioscler Thromb Vasc Biol. 2016 May;36(5):e51.

12.

Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans.

Reyes-Soffer G, Moon B, Hernandez-Ono A, Dionizovik-Dimanovski M, Jimenez J, Obunike J, Thomas T, Ngai C, Fontanez N, Donovan DS, Karmally W, Holleran S, Ramakrishnan R, Mittleman RS, Ginsberg HN.

Sci Transl Med. 2016 Jan 27;8(323):323ra12. doi: 10.1126/scitranslmed.aad2195. Erratum in: Sci Transl Med. 2016 Feb 10;8(325):325er3. Dionizovick-Dimanovski, Marija [corrected to Dionizovik-Dimanovski, Marija].

13.

Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects.

Millar JS, Reyes-Soffer G, Jumes P, Dunbar RL, deGoma EM, Baer AL, Karmally W, Donovan DS, Rafeek H, Pollan L, Tohyama J, Johnson-Levonas AO, Wagner JA, Holleran S, Obunike J, Liu Y, Ramakrishnan R, Lassman ME, Gutstein DE, Ginsberg HN, Rader DJ.

J Clin Invest. 2015 Jun;125(6):2510-22. doi: 10.1172/JCI80025. Epub 2015 May 11. Erratum in: J Clin Invest. 2016 Apr 1;126(4):1603-4.

14.

Impacting delayed pediatric influenza vaccination: a randomized controlled trial of text message reminders.

Hofstetter AM, Vargas CY, Camargo S, Holleran S, Vawdrey DK, Kharbanda EO, Stockwell MS.

Am J Prev Med. 2015 Apr;48(4):392-401. doi: 10.1016/j.amepre.2014.10.023.

PMID:
25812465
15.

Registry-linked electronic influenza vaccine provider reminders: a cluster-crossover trial.

Stockwell MS, Catallozzi M, Camargo S, Ramakrishnan R, Holleran S, Findley SE, Kukafka R, Hofstetter AM, Fernandez N, Vawdrey DK.

Pediatrics. 2015 Jan;135(1):e75-82. doi: 10.1542/peds.2014-2616.

16.

Analysis of geographic variations in the diagnosis and treatment of patients with aortic stenosis in North Carolina.

Vavalle JP, Phillips HR, Holleran SA, Wang A, O'Connor CM, Smith PK, Hughes GC, Harrison JK, Patel MR.

Am J Cardiol. 2014 Jun 1;113(11):1874-8. doi: 10.1016/j.amjcard.2014.03.021. Epub 2014 Mar 22.

PMID:
24837267
17.

Monthly haemostatic factor variability in women and men.

Hill AM, Stewart PW, Fung MK, Kris-Etherton PM, Ginsberg HN, Tracy RP, Pearson TA, Lefevre M, Reed RG, Elmer PJ, Holleran S, Ershow AG; Dietary Effects on Lipoproteins and Thrombogenic Activity Investigators.

Eur J Clin Invest. 2014;44(3):309-18. doi: 10.1111/eci.12235.

18.

Molecular-scale hydrophobic interactions between hard-sphere reference solutes are attractive and endothermic.

Chaudhari MI, Holleran SA, Ashbaugh HS, Pratt LR.

Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20557-62. doi: 10.1073/pnas.1312458110. Epub 2013 Dec 2.

19.

Hypercholesterolemia and reduced HDL-C promote hematopoietic stem cell proliferation and monocytosis: studies in mice and FH children.

Tolani S, Pagler TA, Murphy AJ, Bochem AE, Abramowicz S, Welch C, Nagareddy PR, Holleran S, Hovingh GK, Kuivenhoven JA, Tall AR.

Atherosclerosis. 2013 Jul;229(1):79-85. doi: 10.1016/j.atherosclerosis.2013.03.031. Epub 2013 Apr 19.

20.

Racial/ethnic differences in clinical and biochemical type 2 diabetes mellitus risk factors in children.

Rosenbaum M, Fennoy I, Accacha S, Altshuler L, Carey DE, Holleran S, Rapaport R, Shelov SP, Speiser PW, Ten S, Bhangoo A, Boucher-Berry C, Espinal Y, Gupta R, Hassoun AA, Iazetti L, Jean-Jacques F, Jean AM, Klein ML, Levine R, Lowell B, Michel L, Rosenfeld W.

Obesity (Silver Spring). 2013 Oct;21(10):2081-90. doi: 10.1002/oby.20483. Epub 2013 Jul 5.

21.

Effect of combination therapy with fenofibrate and simvastatin on postprandial lipemia in the ACCORD lipid trial.

Reyes-Soffer G, Ngai CI, Lovato L, Karmally W, Ramakrishnan R, Holleran S, Ginsberg HN.

Diabetes Care. 2013 Feb;36(2):422-8. doi: 10.2337/dc11-2556. Epub 2012 Oct 1.

22.

Trends in the use of diagnostic coronary angiography, percutaneous coronary intervention, and coronary artery bypass graft surgery across North Carolina.

Jones WS, Patel MR, Holleran SA, Harrison JK, O'Connor CM, Phillips HR 3rd.

Am Heart J. 2011 Nov;162(5):932-7. doi: 10.1016/j.ahj.2011.08.015. Epub 2011 Oct 6.

PMID:
22093211
23.

Naturalistically observed sighing and depression in rheumatoid arthritis patients: a preliminary study.

Robbins ML, Mehl MR, Holleran SE, Kasle S.

Health Psychol. 2011 Jan;30(1):129-33. doi: 10.1037/a0021558.

24.

Reading between the lines: the lay assessment of subclinical depression from written self-descriptions.

Rodriguez AJ, Holleran SE, Mehl MR.

J Pers. 2010 Apr;78(2):575-98. doi: 10.1111/j.1467-6494.2010.00627.x.

PMID:
20433631
25.

Eavesdropping on happiness: well-being is related to having less small talk and more substantive conversations.

Mehl MR, Vazire S, Holleran SE, Clark CS.

Psychol Sci. 2010 Apr;21(4):539-41. doi: 10.1177/0956797610362675. Epub 2010 Feb 18. No abstract available.

26.

Endothelial function in individuals with coronary artery disease with and without type 2 diabetes mellitus.

Reyes-Soffer G, Holleran S, Di Tullio MR, Homma S, Boden-Albala B, Ramakrishnan R, Elkind MS, Sacco RL, Ginsberg HN.

Metabolism. 2010 Sep;59(9):1365-71. doi: 10.1016/j.metabol.2009.12.023. Epub 2010 Jan 27.

27.

Measures of postprandial lipoproteins are not associated with coronary artery disease in patients with type 2 diabetes mellitus.

Reyes-Soffer G, Holleran S, Karmally W, Ngai CI, Chen NT, Torres M, Ramakrishnan R, Blaner WS, Berglund L, Ginsberg HN, Tuck C.

J Lipid Res. 2009 Sep;50(9):1901-9. doi: 10.1194/jlr.M900092-JLR200. Epub 2009 May 8.

28.

Emergency response: lessons learned during a community hospital's in situ fire simulation.

Hohenhaus SM, Hohenhaus J, Saunders M, Vandergrift J, Kohler TA, Manikowski ME, Swanson L, Schnure K, Holleran S.

J Emerg Nurs. 2008 Aug;34(4):352-4. doi: 10.1016/j.jen.2008.04.025. No abstract available.

PMID:
18640420
29.

The apolipoprotein(a) gene: linkage disequilibria at three loci differs in African Americans and Caucasians.

Rubin J, Kim HJ, Pearson TA, Holleran S, Berglund L, Ramakrishnan R.

Atherosclerosis. 2008 Nov;201(1):138-47. doi: 10.1016/j.atherosclerosis.2008.01.002. Epub 2008 Mar 4.

30.

Effects of a 1,3-diacylglycerol oil-enriched diet on postprandial lipemia in people with insulin resistance.

Reyes G, Yasunaga K, Rothenstein E, Karmally W, Ramakrishnan R, Holleran S, Ginsberg HN.

J Lipid Res. 2008 Mar;49(3):670-8. Epub 2007 Dec 18.

31.

Anemia in celiac disease is multifactorial in etiology.

Harper JW, Holleran SF, Ramakrishnan R, Bhagat G, Green PH.

Am J Hematol. 2007 Nov;82(11):996-1000.

32.

Lack of correlation of degree of villous atrophy with severity of clinical presentation of coeliac disease.

Brar P, Kwon GY, Egbuna II, Holleran S, Ramakrishnan R, Bhagat G, Green PH.

Dig Liver Dis. 2007 Jan;39(1):26-9; discussion 30-2. Epub 2006 Sep 18.

PMID:
16982222
33.

Change in lipid profile in celiac disease: beneficial effect of gluten-free diet.

Brar P, Kwon GY, Holleran S, Bai D, Tall AR, Ramakrishnan R, Green PH.

Am J Med. 2006 Sep;119(9):786-90.

PMID:
16945614
34.

Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through lipoprotein cholesterol.

Anuurad E, Rubin J, Lu G, Pearson TA, Holleran S, Ramakrishnan R, Berglund L.

J Lipid Res. 2006 Nov;47(11):2475-81. Epub 2006 Aug 3.

35.

Effect of acute cocaine administration on the QTc interval of habitual users.

Magnano AR, Talathoti NB, Hallur R, Jurus DT, Dizon J, Holleran S, Bloomfield DM, Collins E, Garan H.

Am J Cardiol. 2006 Apr 15;97(8):1244-6. Epub 2006 Mar 3.

PMID:
16616034
36.

Apo[a] size and PNR explain African American-Caucasian differences in allele-specific apo[a] levels for small but not large apo[a].

Rubin J, Kim HJ, Pearson TA, Holleran S, Ramakrishnan R, Berglund L.

J Lipid Res. 2006 May;47(5):982-9. Epub 2006 Feb 22.

37.

Treatment with high-dose simvastatin reduces secretion of apolipoprotein B-lipoproteins in patients with diabetic dyslipidemia.

Myerson M, Ngai C, Jones J, Holleran S, Ramakrishnan R, Berglund L, Ginsberg HN.

J Lipid Res. 2005 Dec;46(12):2735-44. Epub 2005 Sep 14.

38.

Postprandial response to a physiologic caloric load in HIV-positive patients receiving protease inhibitor-based or nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy.

Thomas-Geevarghese A, Raghavan S, Minolfo R, Holleran S, Ramakrishnan R, Ormsby B, Karmally W, Ginsberg HN, El-Sadr WM, Albu J, Berglund L.

Am J Clin Nutr. 2005 Jul;82(1):146-54.

PMID:
16002813
39.

Cholesterol-lowering benefits of oat-containing cereal in Hispanic americans.

Karmally W, Montez MG, Palmas W, Martinez W, Branstetter A, Ramakrishnan R, Holleran SF, Haffner SM, Ginsberg HN.

J Am Diet Assoc. 2005 Jun;105(6):967-70.

PMID:
15942550
40.

Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus.

Nagashima K, Lopez C, Donovan D, Ngai C, Fontanez N, Bensadoun A, Fruchart-Najib J, Holleran S, Cohn JS, Ramakrishnan R, Ginsberg HN.

J Clin Invest. 2005 May;115(5):1323-32. Epub 2005 Apr 1.

41.

Effect of gender on the manifestations of celiac disease: evidence for greater malabsorption in men.

Bai D, Brar P, Holleran S, Ramakrishnan R, Green PH.

Scand J Gastroenterol. 2005 Feb;40(2):183-7.

PMID:
15764149
42.

Autonomic modulation of the u wave during sympathomimetic stimulation and vagal inhibition in normal individuals.

Magnano AR, Holleran S, Ramakrishnan R, Reiffel JA, Bloomfield DM.

Pacing Clin Electrophysiol. 2004 Nov;27(11):1484-92.

PMID:
15546302
43.

Methyl isocyanate exposure and growth patterns of adolescents in Bhopal.

Ranjan N, Sarangi S, Padmanabhan VT, Holleran S, Ramakrishnan R, Varma DR.

JAMA. 2003 Oct 8;290(14):1856-7. No abstract available.

PMID:
14532313
44.

Sample size determination.

Dell RB, Holleran S, Ramakrishnan R.

ILAR J. 2002;43(4):207-13. Erratum in: ILAR J. 2003;44(3):239.

45.

Autonomic nervous system influences on QT interval in normal subjects.

Magnano AR, Holleran S, Ramakrishnan R, Reiffel JA, Bloomfield DM.

J Am Coll Cardiol. 2002 Jun 5;39(11):1820-6.

46.

Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians.

Rubin J, Paultre F, Tuck CH, Holleran S, Reed RG, Pearson TA, Thomas CM, Ramakrishnan R, Berglund L.

J Lipid Res. 2002 Feb;43(2):234-44.

47.

Circulating lipoprotein profiles are modulated differently by lipoprotein lipase in obese humans.

Goldberg IJ, Vanni-Reyes T, Ramakrishnan S, Holleran S, Ginsberg HN.

J Cardiovasc Risk. 2000 Feb;7(1):41-7.

PMID:
10785873
48.

HDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjects.

Berglund L, Oliver EH, Fontanez N, Holleran S, Matthews K, Roheim PS, Ginsberg HN, Ramakrishnan R, Lefevre M.

Am J Clin Nutr. 1999 Dec;70(6):992-1000.

PMID:
10584043
49.

A common Hpa I RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the alleles of apolipoprotein E.

Xu Y, Berglund L, Ramakrishnan R, Mayeux R, Ngai C, Holleran S, Tycko B, Leff T, Shachter NS.

J Lipid Res. 1999 Jan;40(1):50-8.

50.

LPL promoter -93T/G transition influences fasting and postprandial plasma triglycerides response in African-Americans and Hispanics.

Talmud PJ, Hall S, Holleran S, Ramakrishnan R, Ginsberg HN, Humphries SE.

J Lipid Res. 1998 Jun;39(6):1189-96.

Supplemental Content

Loading ...
Support Center